We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$353M
AUM Growth
+$18.3M
Cap. Flow
+$4.78M
Cap. Flow %
1.35%
Top 10 Hldgs %
27.53%
Holding
115
New
5
Increased
40
Reduced
34
Closed
2

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$564K
2
CHRW icon
C.H. Robinson
CHRW
+$524K
3
GPI icon
Group 1 Automotive
GPI
+$236K
4
AAPL icon
Apple
AAPL
+$92.4K
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$86.8K

Sector Composition

Rank Sector Weight
1 Technology 14.43%
2 Healthcare 13.36%
3 Consumer Staples 11.59%
4 Industrials 10.86%
5 Consumer Discretionary 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
51
Home Depot
HD
$331B
$2.93M 0.83%
9,425
MGA icon
52
Magna International
MGA
$18.7B
$2.91M 0.82%
51,550
+1,845
+4% +$97.8K
CTAS icon
53
Cintas
CTAS
$81.9B
$2.75M 0.78%
22,120
VTI icon
54
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$2.73M 0.77%
12,380
-79
-0.6% -$16.5K
IJH icon
55
iShares Core S&P Mid-Cap ETF
IJH
$122B
$2.61M 0.74%
49,870
+350
+0.7% +$17.4K
USB icon
56
US Bancorp
USB
$98.2B
$2.5M 0.71%
75,528
+13,040
+21% +$421K
VB icon
57
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$2.24M 0.63%
11,245
-180
-2% -$34K
LLY icon
58
Eli Lilly
LLY
$1.02T
$2.08M 0.59%
4,433
IBB icon
59
iShares Biotechnology ETF
IBB
$9.34B
$2.07M 0.59%
16,286
-53
-0.3% -$6.88K
HYG icon
60
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$2.02M 0.57%
26,867
-18
-0.1% -$1.34K
BBH icon
61
VanEck Biotech ETF
BBH
$400M
$1.99M 0.56%
12,721
IAU icon
62
iShares Gold Trust
IAU
$62.9B
$1.92M 0.54%
52,753
-1,070
-2% -$40.1K
HYD icon
63
VanEck High Yield Muni ETF
HYD
$4.43B
$1.72M 0.49%
33,421
-737
-2% -$37.8K
JNJ icon
64
Johnson & Johnson
JNJ
$618B
$1.62M 0.46%
9,773
GOOG icon
65
Alphabet (Google) Class C
GOOG
$4.36T
$1.43M 0.4%
11,820
CVX icon
66
Chevron
CVX
$392B
$1.39M 0.39%
8,808
-65
-0.7% -$10.4K
SYK icon
67
Stryker
SYK
$125B
$1.33M 0.38%
4,354
ORCL icon
68
Oracle
ORCL
$374B
$1.23M 0.35%
10,319
+112
+1% +$11.6K
VEU icon
69
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$1.2M 0.34%
22,118
-16
-0.1% -$867
VEA icon
70
Vanguard FTSE Developed Markets ETF
VEA
$229B
$1.07M 0.3%
23,116
PFE icon
71
Pfizer
PFE
$143B
$881K 0.25%
24,041
+209
+0.9% +$8.13K
CAT icon
72
Caterpillar
CAT
$375B
$871K 0.25%
3,542
PAYX icon
73
Paychex
PAYX
$41.6B
$858K 0.24%
7,675
PFF icon
74
iShares Preferred and Income Securities ETF
PFF
$13.3B
$718K 0.2%
23,223
-930
-4% -$28.5K
VWO icon
75
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$709K 0.2%
17,438
+2,225
+15% +$89.7K

Similar funds

Boston Research & Management's Q2 2023 Portfolio in Review

As of Q2 2023, Boston Research & Management held 115 positions worth $353M, up 5.5% from $335M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Boston Research & Management's Q2 2023 filing shows 5 new, 40 increased, 34 reduced and 2 closed positions. Its largest new stake was Masco: 4,000 shares worth $229K. The largest sale was Microsoft, an estimated $564K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Boston Research & Management's largest Q2 2023 buy was Masco: 4,000 shares worth $229K.
  • Boston Research & Management added most to Sysco in Q2 2023, an estimated $3.54M increase.
  • Boston Research & Management's biggest Q2 2023 reduction was Microsoft, cutting an estimated $564K.
  • Boston Research & Management fully exited C.H. Robinson in Q2 2023, selling an estimated $524K.
  • Boston Research & Management's ten largest holdings make up 28% of its $353M portfolio in Q2 2023.
  • Boston Research & Management opened 5 new positions and closed 2 in Q2 2023.
  • Boston Research & Management's portfolio value rose 5.5% quarter-over-quarter to $353M.

Based on Boston Research & Management's 13F filing for Q2 2023, filed 1 Aug 2023.